AzTrials
AzTrials

Accidental FallsCFCNCT02292316

Falls With Fracture : Role of Cognitive Disorders and Comparison With Bone Fragility

A study testing gait and cognitive assessments, blood sample and osteodensitometry in people with Accidental Falls and Fractures, run by University Hospital, Caen at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether cognitive disorders are a risk factor for a fracture after a fall independently of a bone fragility. Read more about this study

Who is it for?
Ages 55 years and olderHealthy volunteers can take part
Conditions the study is for
Accidental Falls, Fractures
What is being tested?
gait and cognitive assessments, blood sample and osteodensitometry
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
218 participants
Where
2 sitesFrance
Study dates
15 Nov 2011to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Affiliation to the social security system
  • For subjects with fracture : victim of a low-energy fracture of the upper or lower limb that was consecutive to a fall from standing height, and who has accepted to realize a DXA exam in the context of the medical follow-up
  • For control subjects : victim of a fall from standing height, with no fracture, matched in terms of age, sex, socio-cultural level and living space with subjects with fracture.
  • Written informed consent

Who cannot join

  • Subject who is deprived of liberty, under supervision or legal guardianship
  • Pathology affecting balance (Parkinson's disease, after-effects of stroke, …)
  • Important visual impairment : age-related macular degeneration, …
  • Depressed state
  • Important consumption of alcohol (> 14 drinks per week for women / >21 for men)
  • Subject who is concurrently participating in another clinical study (unless prior notice of the principal investigator)
Show all 14Show fewer
  • Fall has been caused by a third party (e.g. : pushing), is not from standing height (e.g. : fall from a ladder); fracture is not a low-energy one (e.g. : further a fall during running)
  • For subjects with fracture :
  • The fracture is not consecutive to a fall
  • The fracture is pathological, beyond osteoporosis (e.g. : bone metastases)
  • The last fall responsible for a fracture goes back more than 6 months
  • For control subjects :
  • o The fall goes back more than 12 months
  • The fall has led to a medical consultation

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • University Hospital

    Caen, 14000

  • Dr Alain Daragon

    Rouen, 76000

Other trials in France

About this study

The purpose of this study is to determine whether cognitive disorders are a risk factor for a fracture after a fall independently of a bone fragility.

Read the detailed description

The fall is a major problem in the elderly. After 65 year old, falls represent 84% of daily living accidents and almost half of the post fall injuries are fractures (Ricard and Thélot, 2007). These falls with fracture lead to a loss of autonomy and a high health cost. Their prevention is a crucial focus of research.

Even if it is obvious that subjects with osteoporosis have a higher risk of fracture than those with a normal bone mineral density, recent studies have shown that most victims of fracture post-fall do not comply with the densitometric definition of osteoporosis.

It is well established that the presence of cognitive disorders, frequent in the elderly, is an important risk factor for falls; It might also be a risk factor for fracture after a fall with an unadapted postural or balance control.

The investigators will test this hypothesis on 150 victims of fracture (upper or lower limb) consecutive to a fall from standing height, recruited in the hospitals of Caen and Rouen (France) in the context of their medical follow-up (with blood and dual energy x-ray absorptiometry [DXA] exams). These patients will be matched to 150 control participants (victims of a fall with no fracture, submitted to the same exams).

All the participants are subjects to an in-depth study of cognitive functions, postural and walking tests and to various scales (daily life activities, depression, ...).

These exams will take half a day, with a two-year follow up (in which the participant will have to note new falls and new medical treatments)

Being tested
gait and cognitive assessments, blood sample, osteodensitometry
Keywords
middle-aged and aged adults, fall in the previous year
Medical subject headings
Fractures, Bone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gait and cognitive assessmentsBehavioural

    several tests are given in each domain

  • blood sampleBiological

    routine analyses in rheumatology such blood count and 25OH-D

  • osteodensitometryOther

    Looking for osteoporosis

Study groups in NCT02292316
Study groupRoleWhat they receive
Fall with fractureExperimentalFall with fracture in the last 6 months; Interventions : behavioral, biological and other; Behavioral intervention includes gait and cognitive assessments Blood sample Osteodensitometry
Receives: Behavioral: gait and cognitive assessments; Biological: blood sample; Other: osteodensitometry
controlsSham comparatorFall without fracture in the last 12 months; Interventions : behavioral, biological and other; Behavioral intervention includes gait and cognitive assessments Blood sample Osteodensitometry
Receives: Behavioral: gait and cognitive assessments; Biological: blood sample; Other: osteodensitometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analysis of a global cognitive efficiency score Analysis of bone mineral density

    MMS, MoCA

    Measured: on the inclusion day and two years after

Secondary outcomes (11)
  1. Age

    Measured: on the inclusion day and over two years

  2. Cognitive scores

    Mainly tests of memory, attention and executive functions

    Measured: on the inclusion day and over two years

  3. Fracture features

    Location and severity

    Measured: on the inclusion day and over two years

  4. Balance and walking parameters

    Tinetti scale, TUG and dual-tasks

    Measured: on the inclusion day and over two years

  5. handgrip force

    using a dynamometer

    Measured: on the inclusion day and over two years

  6. Daily life scales scores

    Mainly IADL

    Measured: on the inclusion day and over two years

  7. fear of falling

    ABC-scale

    Measured: on the inclusion day and over two years

  8. functional restrictions score

    Lequesne score

    Measured: on the inclusion day and over two years

  9. Degree of depression

    MADRS

    Measured: on the inclusion day and over two years

  10. biological data

    25OHD

    Measured: on the inclusion day and over two years

  11. Dual-energy X-ray absorptiometry

    bone mineral densitometry

    Measured: on the inclusion day and two years after

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2014 (estimated)
  2. Study start15 Nov 2011
  3. Primary completion31 Dec 2017
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
218 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02292316
Sponsor's protocol ID
RCB 2011A00556-35
Acronym
CFC
Status last verified
Mar 2020
First submitted
26 Sep 2014
Last updated
4 Mar 2020
Results posted
No
Data monitoring committee
No

Publications

  • Langeard A, Pothier K, Chastan N, Marcelli C, Chavoix C, Bessot N. Reduced gait and postural stability under challenging conditions in fallers with upper limb fracture. Aging Clin Exp Res. 2019 Apr;31(4):483-489. doi: 10.1007/s40520-018-0992-z. Epub 2018 Jul 4.

    PubMed 29974390
  • Langeard A, Pothier K, Morello R, Lelong-Boulouard V, Lescure P, Bocca ML, Marcelli C, Descatoire P, Chavoix C. Polypharmacy Cut-Off for Gait and Cognitive Impairments. Front Pharmacol. 2016 Aug 31;7:296. doi: 10.3389/fphar.2016.00296. eCollection 2016.

    PubMed 27630572

Questions about this trial

What is this clinical trial studying?

A study testing gait and cognitive assessments, blood sample and osteodensitometry in people with Accidental Falls and Fractures, run by University Hospital, Caen at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analysis of a global cognitive efficiency score Analysis of bone mineral density (time frame: on the inclusion day and two years after). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02292316, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in